Got to News overview News

H2020 grant for a new EATRIS flagship project on personalised medicine

News News

EATRIS, the European infrastructure for translational medicine, obtained funding for a new flagship project for sustainability and personalised medicine: EATRIS-Plus.

The project aims to build further capabilities and deliver innovative scientific tools to support the long-term sustainability of EATRIS. A key output of the project will be the piloting and delivery of a multi-omic toolbox, that will include SOPs, guidelines for best practices, reference materials, quality parameters, analysis tools, criteria for establishing reference values, and will provide access to a repository of multi-omic data. Objectives that are in line with the ambitions of the Netherlands X-omics Initiative, coordinated by Alain van Gool (Radboudumc, partner of Health-RI).

EATRIS covers over 90 institutes across Europe, among which Radboudumc. It has shown strong proof of concept of the value and utility of its translational medicine services portfolio, with users including academia, SMEs, large pharma, biotech and research funding organisations. The overarching aim of EATRIS-Plus is to further support the long-term sustainability of EATRIS by delivering innovative scientific tools to the personalised medicine research community. EATRIS-Plus will help pooling and utilising the translational academic capacities of the infrastructure in omics technologies to enable researchers to better address the scientific and societal challenges of personalised medicine.

EATRIS' flagship project EATRIS-Plus granted by the European Commission

Share this page…